DJIA 17,707.34 21.61 0.12%
NASDAQ 4,699.18 23.47 0.50%
S&P 500 2,051.74 3.02 0.15%
market minute promo


company name or ticker
Company Photos
(Click to zoom)

Roche’s Avastin Gets Approval For Ovarian Cancer, But Incremental Revenues Will Be Small

Will Bristol-Myers Squibb's Dividend Be Safe?

Bristol-Myers Squibb is battling patent expiration, but some fast-growing new drugs just may be able to save its dividend.

Vanguard Value ETF Experiences Big Inflow

The Crucial Thing You're Missing About Many Dividend Stocks

In this edition of "Where the Money Is," one Motley Fool contributor explains why the earnings payout ratio isn't the ratio dividend investors should actually be watching.

Celgene Up on Encouraging Long-Term Phase III Otezla Data - Analyst Blog

Screening Pharma Stocks Amid Turnaround

Johnson & Johnson’s Partnership With Geron Emphasizes Its Push In Oncology

Gilead: Rising Net Income, Zero Debt And Strong R&D Pipeline

Inovio-Roche End Deal for Development of Cancer Therapy - Analyst Blog

Inovio-Roche End Deal for Development of Cancer Therapy - Analyst Blog

Roche's (RHHBY) Avastin Label Expansion Approved by FDA - Analyst Blog

See More Articles...